CEO’s are coming under ever-greater scrutiny from boards, shareholders, legislators and the media. The role is becoming increasingly complex and the burden of expectation is high. CEO tenure is consequently getting shorter and top quality leadership talent is scarce. Identifying the right person to lead an organization requires knowledge, expertise and sound advice. Few decisions are more important for a board than choosing the right CEO to lead the business. These assignments are successful as the Straxon Group closely collaborates with management boards or the investors of the biotech company.  

 

The Straxon Group performed search assignments such as:

-         CEO of a vaccine company and various biotech start-ups,

-         CEO of diagnostic companies,

-         COO of a biotechnology therapeutics / device company

-         COO of a nano technology drug delivery biotech

-         CMO of a biotech therapeutics company